According to Edwards Lifesciences's latest financial reports the company's current EPS (TTM) is $2.45. In 2021 the company made an earnings per share (EPS) of $2.42 an increase over its 2020 EPS that were of $1.32.
Year | EPS | Change |
---|---|---|
2022 (TTM) | $2.45 | 1.24% |
2021 | $2.42 | 83.8% |
2020 | $1.32 | -21.31% |
2019 | $1.67 | 45.93% |
2018 | $1.15 | 16.61% |
2017 | $0.98 | 10.49% |
2016 | $0.89 | 16.34% |
2015 | $0.76 | -40.08% |
2014 | $1.28 | 119.48% |
2013 | $0.58 | 36.86% |
2012 | $0.43 | 23.19% |
2011 | $0.35 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Medtronic MDT | $3.05 | 24.49% | ๐ฎ๐ช Ireland |
![]() Boston Scientific BSX | $0.45 | -81.63% | ๐บ๐ธ USA |
![]() Merit Medical MMSI | $1.31 | -46.53% | ๐บ๐ธ USA |
![]() LeMaitre Vascular LMAT | $0.95 | -61.22% | ๐บ๐ธ USA |
![]() ICU Medical
ICUI | -$3.12 | -227.35% | ๐บ๐ธ USA |